Development and Validation of the PASS Score: A Simplified Tool to Diagnose Acquired Aplastic Anemia in Adults
Preprint
- 22 January 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Acquired aplastic anemia (AA) can present similarly to inherited bone marrow failure syndromes (IBMFS) but treatment differs. AA diagnosis relies on excluding IBMFS; however, genetic testing is not always available, may delay care or be inconclusive. We developed the Predictive Aplastic Score System (PASS), a clinical tool using readily available data to distinguish AA from IBMFS in adults. The training cohort included 212 adults (162 AA, 50 IBMFS). Compared to IBMFS, AA patients were older and more likely to have acute-onset, severe cytopenias. Using logistic regression with LASSO, we selected seven clinical variables for model inclusion: severity, acuity, age, IBMFS red flags, AA-associated conditions, AA-associated somatic changes, and telomere lengths. The model achieved AUC of 0.990 (95% CI: 0.982–0.999), with 100% positive predictive value (PPV) for AA for scores ≥ 30. 86.8% of patients with scores < 0 had IBMFS. We validated PASS in 716 patients from four external cohorts with AUC of 0.977 (95% CI: 0.968–0.987). Threshold analysis confirmed 100% PPV for scores ≥ 30, rapidly diagnosing 80% of AA cases. PASS is a practical and accurate clinical tool that can rapidly distinguish AA from IBMFS for most adult patients. To promote clinical adoption, we developed open-access web calculator (https://pennmedicine.shinyapps.io/passcalc/).Keywords
All Related Versions
- Version 1, 2026-01-22, Research Square
- Published version: Leukemia, 40 (7), 1411.
This publication has 47 references indexed in Scilit:
- Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndromeBone Marrow Transplantation, 2008
- Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow TransplantationHaematologica, 2007
- Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure SyndromesHematology-American Society Hematology Education Program, 2007
- PIG-A mutations in normal hematopoiesisBlood, 2005
- Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAThe Lancet, 2003
- Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyTransplantation and Cellular Therapy, 1999
- Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individualsProceedings of the National Academy of Sciences, 1999
- Aplastic anemia after non-A, non-B, and non-C hepatitis.1994
- Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.1987
- Pathogenesis and treatment of aplastic anemia.1984